Standard
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms : influence of ruxolitinib, interferon-α2, or combination treatment. / Sørensen, Anders Lindholm; Bjørn, Mads Emil; Riley, Caroline H.; Holmstrøm, Morten; Andersen, Mads Hald; Svane, Inge Marie; Mikkelsen, Stine Ulrik; Skov, Vibe; Kjær, Lasse; Hasselbalch, Hans C.; Nielsen, Claus H.
I:
European Journal of Haematology, Bind 103, Nr. 4, 2019, s. 351-361.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Sørensen, AL, Bjørn, ME, Riley, CH, Holmstrøm, M
, Andersen, MH, Svane, IM, Mikkelsen, SU, Skov, V, Kjær, L, Hasselbalch, HC & Nielsen, CH 2019, '
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment',
European Journal of Haematology, bind 103, nr. 4, s. 351-361.
https://doi.org/10.1111/ejh.13292APA
Sørensen, A. L., Bjørn, M. E., Riley, C. H., Holmstrøm, M.
, Andersen, M. H., Svane, I. M., Mikkelsen, S. U., Skov, V., Kjær, L., Hasselbalch, H. C., & Nielsen, C. H. (2019).
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment.
European Journal of Haematology,
103(4), 351-361.
https://doi.org/10.1111/ejh.13292Vancouver
Sørensen AL, Bjørn ME, Riley CH, Holmstrøm M
, Andersen MH, Svane IM o.a.
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment.
European Journal of Haematology. 2019;103(4):351-361.
https://doi.org/10.1111/ejh.13292Author
Sørensen, Anders Lindholm ; Bjørn, Mads Emil ; Riley, Caroline H. ; Holmstrøm, Morten ; Andersen, Mads Hald ; Svane, Inge Marie ; Mikkelsen, Stine Ulrik ; Skov, Vibe ; Kjær, Lasse ; Hasselbalch, Hans C. ; Nielsen, Claus H. / B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms : influence of ruxolitinib, interferon-α2, or combination treatment. I: European Journal of Haematology. 2019 ; Bind 103, Nr. 4. s. 351-361.
Bibtex
@article{46553e45247247139198a24fbf7017c1,
title = "B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment",
author = "S{\o}rensen, {Anders Lindholm} and Bj{\o}rn, {Mads Emil} and Riley, {Caroline H.} and Morten Holmstr{\o}m and Andersen, {Mads Hald} and Svane, {Inge Marie} and Mikkelsen, {Stine Ulrik} and Vibe Skov and Lasse Kj{\ae}r and Hasselbalch, {Hans C.} and Nielsen, {Claus H.}",
year = "2019",
doi = "10.1111/ejh.13292",
language = "English",
volume = "103",
pages = "351--361",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "4",
}
RIS
TY - JOUR
T1 - B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms
T2 - influence of ruxolitinib, interferon-α2, or combination treatment
AU - Sørensen, Anders Lindholm
AU - Bjørn, Mads Emil
AU - Riley, Caroline H.
AU - Holmstrøm, Morten
AU - Andersen, Mads Hald
AU - Svane, Inge Marie
AU - Mikkelsen, Stine Ulrik
AU - Skov, Vibe
AU - Kjær, Lasse
AU - Hasselbalch, Hans C.
AU - Nielsen, Claus H.
PY - 2019
Y1 - 2019
U2 - 10.1111/ejh.13292
DO - 10.1111/ejh.13292
M3 - Journal article
C2 - 31297883
VL - 103
SP - 351
EP - 361
JO - European Journal of Haematology
JF - European Journal of Haematology
SN - 0902-4441
IS - 4
ER -
